Zomedica (ZOM) - 2019 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 For the transition period from ______________________________ to ______________________________ Commission file number: 001-38298 ZOMEDICA PHARMACEUTICALS CORP. Alberta, Canada N/A (State or other jurisdiction of (I.R.S. Employer Incorporation or organization) Identification No.) 100 Phoenix Drive, Suite ...